Advanced Medical Solutions Group plc Stock

Equities

AMS

GB0004536594

Medical Equipment, Supplies & Distribution

Delayed London S.E. 08:42:14 2024-04-24 am EDT 5-day change 1st Jan Change
192 GBX +0.85% Intraday chart for Advanced Medical Solutions Group plc +4.36% -7.46%
Sales 2023 126M 157M Sales 2024 * 178M 222M Capitalization 414M 515M
Net income 2023 15M 18.65M Net income 2024 * 9M 11.19M EV / Sales 2023 3.1 x
Net cash position 2023 60.16M 74.82M Net Debt 2024 * 12.31M 15.31M EV / Sales 2024 * 2.39 x
P/E ratio 2023
28.6 x
P/E ratio 2024 *
41.9 x
Employees 800
Yield 2023
1.14%
Yield 2024 *
1.38%
Free-Float 97.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.84%
1 week+4.35%
Current month-2.04%
1 month+3.23%
3 months-6.80%
6 months+1.48%
Current year-7.47%
More quotes
1 week
180.20
Extreme 180.2
192.25
1 month
176.60
Extreme 176.6
199.20
Current year
176.60
Extreme 176.6
220.00
1 year
165.60
Extreme 165.6
261.00
3 years
165.60
Extreme 165.6
347.00
5 years
165.60
Extreme 165.6
357.21
10 years
106.85
Extreme 106.8545
374.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 05-06-30
Director of Finance/CFO 52 11-10-04
Chief Tech/Sci/R&D Officer - 01-12-31
Members of the board TitleAgeSince
Director/Board Member 66 21-01-31
Chief Executive Officer 57 05-06-30
Director/Board Member 58 21-08-01
More insiders
Date Price Change Volume
24-04-24 192 +0.85% 246 214
24-04-23 190.4 +1.49% 284,402
24-04-22 187.6 +2.18% 427,467
24-04-19 183.6 -0.43% 218,849
24-04-18 184.4 +0.22% 344,397

Delayed Quote London S.E., April 24, 2024 at 07:31 am EDT

More quotes
Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of novel tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. It operates through two divisions for its sales, marketing and research and development (R&D) activities, including Surgical and Woundcare. Its surgical business unit is focused on selling and marketing its branded products and are sold directly and through distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under their own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1.904 GBP
Average target price
2.522 GBP
Spread / Average Target
+32.47%
Consensus